Montreal (ots/PRNewswire) - CellCarta, ein globaler Anbieter von Dienstleistungen im Bereich der Präzisionsmedizin, gab heute die Übernahme von Reveal Biosciences ("Reveal") bekannt, einem in San Diego
11 maggio 2021 14:35
Fonte: Adnkronos
#chimica-e-farmacia
- MONTREAL, May 11, 2021 /PRNewswire/ CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences ( Reveal ), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. This acquisition further strengthens CellCarta s position as a leading provider of histopathology biomarker services and will enable the company to broaden its offering in AI-enabled multi-omic data analysis services and applications.
Reveal Biosciences has created a new generation of Pathology Intelligence™ to enhance research, clinical trials, and improve patient outcomes globally. Reveal s imageDx™ pathology platform combines cutting edge machine learning (ML)-AI with traditional histopathology to transform tissue biology into actionable data.
Reveal Biosciences Logo (CNW Group/CellCarta)
MONTREAL, May 11, 2021 /PRNewswire/ - CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences ( Reveal ), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. This acquisition further strengthens CellCarta s position as a leading provider of histopathology biomarker services and will enable the company to broaden its offering in AI-enabled multi-omic data analysis services and applications.
Reveal Biosciences has created a new generation of Pathology Intelligence™ to enhance research, clinical trials, and improve patient outcomes globally. Reveal s imageDx™ pathology platform combines cutting edge machine learning (ML)-AI with traditional histopathology to transform tissue biology into actionable data. Reveal s uniq